Elaine Chungmin Lee

This inventor holds 10 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Chungmin Lee. Retrieved from https://idiyas.com/inventor/elaine-chungmin-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 7.0

ph-index = 9

Forward Citations = 474(Granted Patents)

Location History:

Cambridge, MA (US) (2013 - 2014)
Arlington, MA (US) (2014 - 2023)

Company Filing History:

10 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2013-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11578062 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2023-02-14),

2. 10906891 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2021-02-02),

3. 10081621 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2018-09-25),

4. 10071979 - Process of producing cycloalkylcarboxamido-indole compounds (2018-09-11),

5. 9051303 - [object Object] (2015-06-09),

6. 9035072 - Process of producing cycloalkylcarboxamido-indole compounds (2015-05-19),

7. 8884018 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2014-11-11),

8. 8802868 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide (2014-08-12),

9. 8754222 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2014-06-17),

10. 8344147 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2013-01-01),

Title: Elaine Chungmin Lee: Innovator in Pharmaceutical Chemistry

Introduction

Elaine Chungmin Lee is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. Her work focuses on the development of innovative solid forms of pharmaceutical compounds.

Latest Patents

Among her latest patents is a groundbreaking invention related to solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide. This invention pertains to the pharmaceutical compositions of this compound in substantially crystalline form (Form A) or amorphous form, along with methods of treatment utilizing these compositions.

Career Highlights

Elaine is currently employed at Vertex Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to the creation of effective treatments.

Collaborations

Elaine has collaborated with notable coworkers, including Robert Michael Hughes and Benjamin Joseph Littler, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Elaine Chungmin Lee exemplifies the spirit of innovation in pharmaceutical chemistry, with her patents paving the way for new treatment options. Her contributions are invaluable to the field and highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.